Membrane Radiolabelling of Exosomes for Comparative Biodistribution Analysis in Immunocompetent and Immunodeficient Mice - A Novel and Universal Approach

Abstract

Extracellular vesicles, in particular exosomes, have recently gained interest as novel drug delivery vectors due to their biological origin and inherent intercellular biomolecule delivery capability. An in-depth knowledge of their in vivo biodistribution is therefore essential. This work aimed to develop a novel, reliable and universal method to radiolabel exosomes to study their in vivo biodistribution. Methods : Melanoma (B16F10) cells were cultured in bioreactor flasks to increase exosome yield. B16F10-derived exosomes (Exo B16 ) were isolated using ultracentrifugation onto a single sucrose cushion, and were characterised for size, yield, purity, exosomal markers and morphology using nanoparticle tracking analysis (NTA), protein measurements, flow cytometry and electron microscopy. Exo B16 were radiolabelled using 2 different approaches - intraluminal labelling (entrapment of 111 Indium via tropolone shuttling); and membrane labelling (chelation of 111 Indium via covalently attached bifunctional chelator DTPA-anhydride). Labelling efficiency and stability was assessed using gel filtration and thin layer chromatography. Melanoma-bearing immunocompetent (C57BL/6) and immunodeficient (NSG) mice were injected intravenously with radiolabelled Exo B16 (1x10 11 particles/mouse) followed by metabolic cages study, whole body SPECT-CT imaging and ex vivo gamma counting at 1, 4 and 24 h post-injection. Results : Membrane-labelled Exo B16 showed superior radiolabelling efficiency and radiochemical stability (19.2 ± 4.53 % and 80.4 ± 1.6 % respectively) compared to the intraluminal-labelled exosomes (4.73 ± 0.39 % and 14.21 ± 2.76 % respectively). Using the membrane-labelling approach, the in vivo biodistribution of Exo B16 in melanoma-bearing C57Bl/6 mice was carried out, and was found to accumulate primarily in the liver and spleen (~56% and ~38% ID/gT respectively), followed by the kidneys (~3% ID/gT). Exo B16 showed minimal tumour i.e. self-tissue accumulation (~0.7% ID/gT). The membrane-labelling approach was also used to study Exo B16 biodistribution in melanoma-bearing immunocompromised (NSG) mice, to compare with that in the immunocompetent C57Bl/6 mice. Similar biodistribution profile was observed in both C57BL/6 and NSG mice, where prominent accumulation was seen in liver and spleen, apart from the significantly lower tumour accumulation observed in the NSG mice (~0.3% ID/gT). Conclusion : Membrane radiolabelling of exosomes is a reliable approach that allows for accurate live imaging and quantitative biodistribution studies to be performed on potentially all exosome types wi...

Design of experiment (DoE)‐driven in vitro and in vivo uptake studies of exosomes for pancreatic cancer delivery enabled by copper‐free click chemistry‐based labelling

“…The preferential uptake of PANC-1 Exo by their parent PANC-1 cells was recapitulated in vivo, as demonstrated by the significantly higher uptake of the former in PANC-1 tumours than that in the more vascularised B16-F10 tumours ( Figure 6) [42]. It is worth noting that although B16-F10 cells were predicted by the DoE modelling to show preferential uptake of self-B16-F10 Exo in vitro in this study, which was observed with actual experimental investigation in our previous work, preferential uptake by B16-F10 tumours was not observed in vivo in the same previous study [32]. It was described earlier that expression of CD47 on exosome membranes confers protection from clearance by circulating macrophages and therefore prolongs the circulation time of exosomes in vivo [5].…”

Exosomes: Beyond stem cells for cardiac protection and repair

“…100 An alternate approach for biodistribution analysis is membrane radiolabeling of exosomes. 101 It is worth emphasizing that although this review of the literature is focused on the delivery of therapeutic exosomes, endogenous EVs play detrimental roles in a number of pathological processes, including MI. 47 Distinct strategies are aimed at blocking the assembly, release and uptake of endogenous EVs, 102 modifying their composition, and removing them from the circulation.…”

Exosomes in Gliomas: Biogenesis, Isolation, and Preliminary Applications in Nanomedicine

“…Ultracentrifugation (UC)-based isolation is the most commonly used technique [ 51 , 54 , 55 , 56 , 57 , 58 , 59 ] according to a worldwide International Society for Extracellular Vesicles (ISEV) survey [ 60 ].…”